Efficacy of IVIG plus Rituximab Desensitization Therapy on HLA Antibodies is Independent of HLA Loci.

被引：0
|
作者：
Zhang, X. [1 ]
Jordan, S. [2 ]
机构：
[1] Cedars Sinai Hlth Syst, Comprehens Transplant Ctr, HLA & Immunogenet Lab, Los Angeles, CA USA
[2] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Los Angeles, CA 90048 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A146
引用
收藏
页码：524 / 525
页数：2
相关论文
共 50 条
  • [31] Carfilzomib-Based Desensitization: Effects on HLA, Non-HLA, Auto, and Antiviral Antibodies
    Tremblay, S.
    Portwood, E.
    Shields, A. R.
    Alloway, R. R.
    Brailey, P. A.
    Woodle, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 430 - 431
  • [32] Incidence and Severity of BK Viremia (BKV) after Desensitization with IVIG plus Rituximab (RIT)
    Barbosa, D.
    Kahwaji, J.
    Puliyanda, D.
    Mirocha, J.
    Villicana, R.
    Peng, A.
    Jordan, S.
    Vo, A.
    Toyoda, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 111 - 111
  • [33] Efficacy of Desensitization Therapy for Donor-Specific Anti-HLA Antibodies in Patients Undergoing Haploidentical Hematopoietic Cell Transplant
    Atkins, Jordan Jerrell
    Slade, Michael
    DiPersio, John F.
    Westervelt, Peter
    Vij, Ravi
    Gao, Feng
    Zou, Jun
    Romee, Rizwan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S339 - S340
  • [34] Interim Analysis of a Double-Blinded Placebo Controlled Trial of IVIG v. IVIG plus Rituximab for Desensitization of Highly-HLA Sensitized (PRA >80%) (HS) Deceased Donor (DD) Candidates
    Vo, A.
    Choi, J.
    Lukovsky, M.
    Toyoda, M.
    Ge, S.
    Kahwaji, J.
    Peng, A.
    Villicana, R.
    Najjar, R.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 76 - 77
  • [35] Desensitization-resistant eplet-specific HLA antibodies
    Akgul, Sebahat
    Aslanhan, Umit
    Kazamzadeh, Reza
    Alan, Yaren
    Demir, Erol
    Salli, Deniz Ece
    Tabatabaei, Amir
    Catalbasyan, Talin
    Demir, Demir Kaan
    Kanbay, Mehmet
    Kocak, Burak
    Susal, Caner
    TRANSPLANTATION, 2024, 108 (09) : 19 - 19
  • [36] Desensitization-resistant eplet-specific HLA antibodies
    Akgul, Sebahat
    Aslanhan, Umit
    Kazamzadeh, Reza
    Alan, Yaren
    Demir, Erol
    Ece Salli, Deniz
    Tabatabaei, Amir
    Catalbasyan, Talin
    Kaan Demir, Demir
    Kanbay, Mehmet
    Kocak, Burak
    Susal, Caner
    TRANSPLANTATION, 2024, 108 (9S)
  • [37] Quantifying HLA-specific antibodies in patients undergoing desensitization
    Zachary, Andrea
    Reinsmoen, Nancy L.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2011, 16 (04) : 410 - 415
  • [38] Evidence for linkage of HLA loci in juvenile idiopathic oligoarthritis - Independent effects of HLA-A and HLA-DRB1
    Zeggini, E
    Donn, RP
    Ollier, WER
    Thomson, W
    ARTHRITIS AND RHEUMATISM, 2002, 46 (10): : 2716 - 2720
  • [39] Infectious Outcomes in Kidney Transplant Recipients Treated with IVIG and Rituximab (IVIG plus RIT) for Desensitization Versus Non-Rituximab Treated Recipients.
    Kahwaji, J.
    Sinha, A.
    Toyoda, M.
    Ge, S.
    Reinsmoen, N.
    Lai, C. -H.
    Cao, K.
    Villicana, R.
    Peng, A.
    Jordan, S.
    Vo, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 322 - 322
  • [40] Long Term Outcomes in Highly-HLA Sensitized (HS) Patients Receiving Desensitization with IVIG and Single-Dose (SD) Rituximab.
    Vo, Ashley A.
    Cao, Kai
    Lai, Chih-Hung
    Reinsmoen, Nancy
    Toyoda, Mieko
    Ge, Shili
    Peng, Alice
    Villicana, Rafael
    Jordan, Stanley C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 557 - 557
12345